Ridgefield, Conn., October 15, 2021 Boehringer Ingelheim announced the U.S. Food and Drug Administration (FDA) approved the supplemental Biologics License Application (sBLA) for Cyltezo® (adalimumab-adbm) as the first Interchangeable biosimilar with Humira® (adalimumab). The FDA originally approved Cyltezo® in 2017 for the treatment of multiple chronic inflammatory diseases and this latest approval designates…
Basel, 15 October 2021 Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the US Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab) as adjuvant treatment, following surgery and platinum-based chemotherapy, for adults with Stage II-IIIA non-small cell lung cancer (NSCLC) whose tumours express PD-L1≥1%, as determined by an FDA-approved…
Oct 14, 2021 Hyderabad-based Dr Reddy's Laboratories has become the first Indian pharmaceutical company to launch an anti-cancer drug Abiraterone Acetate in the Chinese market, India's ambassador to China Vikram Misri said in a tweet on October 13. The drug used in cancer treatment is a therapeutic equivalent generic version…
INDIANAPOLIS, Oct. 13, 2021 The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's (NYSE: LLY) Verzenio® (abemaciclib), in combination with endocrine therapy (tamoxifen or an aromatase inhibitor), for the adjuvant treatment of adult patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), node-positive, early…
KENILWORTH, N.J. October 13, 2021 Eastern Daylight Time The FDA approved combining Merck & Co.'s anti-PD-1 therapy Keytruda (pembrolizumab) plus chemotherapy, with or without Roche's Avastin (bevacizumab), for patients with persistent, recurrent or metastatic cervical cancer whose tumours express PD-L1 with a combined positive score (CPS) ≥1. The approval is…
AHMEDABAD, India, Oct. 12, 2021 Intas Pharmaceuticals, has made a progressive breakthrough in the Antifungal Therapy domain with the launch of the world's first Super Bioavailable Itraconazole-SB 100mg by the Brand Name of Itaspor-SB Forte/Subawin. It has been recently approved by Indian Regulatory Authorities. Conventional Itraconazole mainstay drug to fight fungal infection…